Loading company…
MacroCure, based in Petah Tikva, Israel, develops advanced treatments for chronic wounds such as diabetic ulcers.
Headquartered in Petah Tikva, Israel, MacroCure develops treatments for chronic and complex wounds, including diabetic ulcers, pressure sores and venous leg ulcers, sold mainly to hospitals and clinics. The company was founded by Mitchell Shirvan. Its IPO on July 30, 2014 raised USD 54.00 mn by selling 5.4 million shares at USD 10 per share on NASDAQ, and it has made 3 deals in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in